Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis

Clinical trial NCT03303950 · TERMINATED

Trial details

NCT number: NCT03303950
Sponsor: University of Utah
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Anemia ASXL1 Gene Mutation EZH2 Gene Mutation IDH1 Gene Mutation IDH2 Gene Mutation Plasma Cell Myeloma Primary Myelofibrosis Recurrent Plasma Cell Myeloma Secondary Myelofibrosis Thrombocytopenia

Start date: 2018-03-30
Primary completion: 2019-05-14
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.